Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the House Dust Mite Allergy Market?
The market for house dust mite allergy has experienced fast expansion in the last few years. Its growth is projected to increase from $2.11 billion in 2024 to $2.39 billion in 2025, experiencing a compound annual growth rate (CAGR) of 13.0%. The prior growth can be accredited to factors such as heightened awareness and education, progress in diagnostic techniques, relevant research and clinical trials, development of healthcare infrastructure, and regulatory guidelines and standards.
What Growth Rate Is Forecasted for the House Dust Mite Allergy Market by 2029?
Expectations suggest a swift expansion in the house dust mite allergy market over the next few years. The market is set to escalate to a value of $4.1 billion by 2029, reflecting a compound annual growth rate (CAGR) of 14.5%. This proximate growth can be associated with factors such as regulatory encouragement and allergen labeling, a rise in allergy cases, the adoption of telemedicine and remote care, a heightened focus on precision medicine, and an increase in allergen-avoidance products. The forecast period will also be characterized by significant trends including public health awareness drives, digital health solutions incorporation, emphasis on indoor environmental quality, growth in immunotherapy solutions, and advancements in allergen avoidance product technologies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9304&type=smp
Which Key Companies Are Shaping the Future of the House Dust Mite Allergy Market?
Major companies operating in the house dust mite allergy market include Allergy Therapeutics Plc, Bayer AG, Catalent Inc., GSK Plc, Merz Pharma GmbH & Co KGaA, Sanofi S A, Shionogi & Co. Ltd., Stallergenes Greer International AG, Merck & Co. Inc., Torii Pharmaceutical Co. Ltd., Ergomed PLC, DMS Group, HAL Allergy Group, Trio Lifescience Private Limited, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Johnson and Johnson Inc., Circassia Pharmaceuticals Plc, Biomay Ag, GlaxoSmithKline
Which Factors Are Driving Demand in the House Dust Mite Allergy Industry?
The increasing presence of asthma ailments is anticipated to spur the expansion of the house dust mite allergy market. Asthma, a condition causing the airways to narrow, inflame, and occasionally produce excessive mucus, impacts the lungs and causes respiratory difficulties. People with asthma can be more susceptible to dust allergies, compounding their symptoms and necessitating various anti-allergic medications. Consequently, the mounting incidence of asthma elevates the need for house dust mite allergy treatments. For example, in September 2024, data from the Asthma and Allergy Foundation of America, a community-based organization in the U.S., revealed that approximately 10 U.S. individuals die from asthma each day, resulting in 3,235 deaths in 2022. Most of these tragedies could have been avoided with appropriate treatment and attention. As a result, the pervasiveness of asthma disorders is propelling the growth of the house dust mite allergy market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9304&type=smp
How Is the House Dust Mite Allergy Market Segmented by Several Divisions?
The house dust mite allergy market covered in this report is segmented –
1) By Product Type: Tablets, Nasal Drops, Injectable
2) By Treatment Type: Medication, Immunotherapy, Nasal Irrigation, Other Types
3) By Diagnosis: Skin Prick Test (SPT), Specific Immunoglobulin E (IgE) Blood Test, Other Diagnosis
4) By Dosage Forms: Solid, Liquid
5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Tablets: Sublingual Tablets, Oral Tablets
2) By Nasal Drops: Antihistamine Nasal Drops, Corticosteroid Nasal Drops
3) By Injectable: Allergen Immunotherapy Injections, Corticosteroid Injections
What are the Emerging Market Trends Driving the Growth of the House Dust Mite Allergy Industry?
Leading businesses in the house dust mite allergy market are concentrating their efforts on creating innovative solutions such as sublingual tablets to combat the growing occurrence of such allergies. Sublingual tablets for this purpose constitute an immunotherapy method wherein a tablet is placed under the tongue, dissolves, and releases small amounts of the allergenic substance causing the reaction. A case in point is the ALK-Abelló A/S, a Denmark-based pharmaceutical firm, which in January 2023 received FDA clearance for their product, ODACTRA, a sublingual tablet targeting house dust mite allergies in teenagers between 12 and 17 years old. This expanded their earlier adult market reach. This approval addresses a large market as nearly half of all allergy victims show sensitivity to house dust mites. Clinical experiments show that ODACTRA effectively lessens allergy symptoms and has a safety profile similar to that seen in adult patients. Despite being generally well-received by patients, they are instructed to keep auto-injectable epinephrine available due to the risk of intense allergic reactions.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/house-dust-mite-allergy-global-market-report
Which Regions Are Driving Growth in the House Dust Mite Allergy Market?
North America was the largest region in the house dust mite allergy market in 2024. Asia-pacific is expected to be the fastest-growing region in the house dust mite allergy market report during the forecast period. The regions covered in the house dust mite allergy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9304
This Report Delivers Insight On:
1. How big is the house dust mite allergy market, and how is it changing globally?
2. Who are the major companies in the house dust mite allergy market, and how are they performing?
3. What are the key opportunities and risks in the house dust mite allergy market right now?
4. Which products or customer segments are growing the most in the house dust mite allergy market?
5. What factors are helping or slowing down the growth of the house dust mite allergy market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
